etubics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://immunitybio.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Immunotherapy by ImmunityBio - Cell Therapy for
Description Researching Ways to Prevent ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy
Keywords N/A
Server Information
WebSite etubics faviconetubics.com
Host IP 74.206.101.41
Location United States
Related Websites
Site Rank
More to Explore
etubics.com Valuation
US$1,737
Last updated: 2023-05-16 13:27:14

etubics.com has Semrush global rank of 0. etubics.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. etubics.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 74.206.101.41. According to SiteAdvisor, etubics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,737
Daily Ads Revenue US$1
Monthly Ads Revenue US$48
Yearly Ads Revenue US$577
Daily Unique Visitors 13
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
etubics.com. A 600 IP: 74.206.101.41
etubics.com. NS 3600 NS Record: pdns11.domaincontrol.com.
etubics.com. NS 3600 NS Record: pdns12.domaincontrol.com.
etubics.com. MX 3600 MX Record: 10 ALT3.ASPMX.L.GOOGLE.com.
etubics.com. MX 3600 MX Record: 5 ALT2.ASPMX.L.GOOGLE.com.
etubics.com. MX 3600 MX Record: 5 ALT1.ASPMX.L.GOOGLE.com.
etubics.com. MX 3600 MX Record: 10 ALT4.ASPMX.L.GOOGLE.com.
etubics.com. MX 3600 MX Record: 1 ASPMX.L.GOOGLE.com.
etubics.com. TXT 600 TXT Record: hda7qt1o9eh1iafn8018626aot
etubics.com. TXT 600 TXT Record: google-site-verification=9jWxBUHxzWai6nHwwDHCnzJ0mqS8gFySkT39A3QVdj4
etubics.com. TXT 600 TXT Record: google-site-verification=s5MJYVdH6HUXoV5ATHm_PArphPi68BA7vyg9R3dWq4I
etubics.com. TXT 600 TXT Record: v=spf1 a mx ptr include:secureserver.net ~all
HtmlToTextCheckTime:2023-05-16 13:27:14
Our Science Platforms Pipeline Expanded Access Research Unique Approach Patients Trial Investigators Researchers Therapies Bladder Cancer Glioblastoma Lynch Syndrome Non-Small Cell Lung Cancer Pancreatic Cancer COVID-19 HIV Our Company About Us Investors News Contact Careers Get Started Find a Trial Become a Trial Investigator License our Cells Select Page Researching Ways to Prevent Cancer ImmunityBio is working with the National Cancer Institute on the largest Lynch syndrome cancer prevention study in the U.S. People with hereditary Lynch syndrome can develop colorectal cancer decades earlier than average, and have increased risk of developing additional cancers. Learn More Finding Better Treatments for Bladder Cancer We are pleased to report that the FDA has accepted for review our BLA for N-803 + BCG for BCG-Unresponsive NMIBC CIS. If approved, N-803 plus BCG would be the first immunotherapy combination for this indication in 23 years that can be delivered directly to the bladder
HTTP Headers
HTTP/1.1 302 Found
Date: Fri, 28 Jan 2022 10:08:45 GMT
Server: Apache/2.4.46 (IUS) OpenSSL/1.0.2k-fips PHP/7.4.19
Strict-Transport-Security: max-age=15768000
X-Frame-Options: SAMEORIGIN
Location: https://etubics.com/
Cache-Control: max-age=86400
Expires: Sat, 29 Jan 2022 10:08:45 GMT
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 302 Found
Date: Fri, 28 Jan 2022 10:08:40 GMT
Server: Apache/2.4.46 (IUS) OpenSSL/1.0.2k-fips PHP/7.4.19
Strict-Transport-Security: max-age=15768000
X-Frame-Options: SAMEORIGIN
Location: https://immunitybio.com/
Cache-Control: max-age=86400
Expires: Sat, 29 Jan 2022 10:08:40 GMT
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
date: Fri, 28 Jan 2022 10:08:44 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RvLO1GQGXKRJHrLHPlmS%2BbWPtD4rJDLArT3yW%2FE3QD9VnUQKVfM6nBhSoVkg0Go%2BIxUWSSkHQairpgxyAvMkCQ0vZyN4W9OoFfxM5ah%2BInlzULiwfOiKBpcUlg6wgvMpjA%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6d496bd17fc49113-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
etubics.com Whois Information
Domain Name: ETUBICS.COM
Registry Domain ID: 97069789_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-02-12T03:28:09Z
Creation Date: 2003-04-22T04:48:37Z
Registry Expiry Date: 2022-04-22T04:48:37Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: PDNS11.DOMAINCONTROL.COM
Name Server: PDNS12.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-28T07:30:56Z <<<

Copyright © 2022 WebZZ.US 0.0212